サンガー法シーケンシングサービスの世界市場:用途別(診断、バイオマーカー・がん、リプロダクティブヘルス、オーダーメイド医療、化学捜査、その他)、エンドユーザー別(学術・政府研究機関、製薬会社、バイオテクノロジー企業、病院・診療所)

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:AMR805013)
◆英語タイトル:Sangers Sequencing Service Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others) and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) - Global Opportunity Analysis and Industry Forecast, 2013-2025
◆発行会社/調査会社:Allied Market Research
◆商品コード:AMR805013
◆発行日:2018年4月20日
◆調査対象地域:グローバル
◆産業分野:医療
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single UserUSD5,370 ⇒換算¥585,330見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥703,050見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥980,455見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サンガー法シーケンシングサービスの世界市場:用途別(診断、バイオマーカー・がん、リプロダクティブヘルス、オーダーメイド医療、化学捜査、その他)、エンドユーザー別(学術・政府研究機関、製薬会社、バイオテクノロジー企業、病院・診療所)]についてメールでお問い合わせはこちら
本資料は、サンガー法シーケンシングサービスの世界市場について調べ、サンガー法シーケンシングサービスの世界規模、市場シェア、市場動向、市場環境、用途別(診断、バイオマーカー・がん、リプロダクティブヘルス、オーダーメイド医療、化学捜査、その他)分析、エンドユーザー別(学術・政府研究機関、製薬会社、バイオテクノロジー企業、病院・診療所)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・サンガー法シーケンシングサービスの世界市場概要
・サンガー法シーケンシングサービスの世界市場環境
・サンガー法シーケンシングサービスの世界市場動向
・サンガー法シーケンシングサービスの世界市場規模
・サンガー法シーケンシングサービスの世界市場:市場シェア
・サンガー法シーケンシングサービスの世界市場:用途別(診断、バイオマーカー・がん、リプロダクティブヘルス、オーダーメイド医療、化学捜査、その他)
・サンガー法シーケンシングサービスの世界市場:エンドユーザー別(学術・政府研究機関、製薬会社、バイオテクノロジー企業、病院・診療所)
・サンガー法シーケンシングサービスの世界市場:地域別市場規模・分析
・サンガー法シーケンシングサービスの北米市場規模・予測
・サンガー法シーケンシングサービスのアメリカ市場規模・予測
・サンガー法シーケンシングサービスのヨーロッパ市場規模・予測
・サンガー法シーケンシングサービスのアジア市場規模・予測
・サンガー法シーケンシングサービスの日本市場規模・予測
・サンガー法シーケンシングサービスの中国市場規模・予測
・関連企業情報
*** レポート概要(サマリー)***

Sanger’s sequencing method is based on the principle of detecting labelled chain-terminating nucleotides, which are incorporated by a DNA polymerase during the replication of a template. This method of sequencing is also known as chain termination or dideoxy sequencing. The global Sanger’s sequencing service market was valued at $192 million in 2013, and is estimated to reach at $1,085 million by 2025, registering a CAGR of 14.2% from 2018 to 2025.

As Sanger’s sequencing is known as the gold standard of sequencing technologies, as it offers long read capability and a high-degree of accuracy. Sanger’s sequencing services are routinely offered by sequencing companies to different end users such as academic institutes and hospitals for sequence analysis.

Advantages associated with Sanger’s sequencing, technological advancements in sequencing procedures, and surge in application of Sanger’s sequencing are the key factors that boost market growth. Furthermore, increase in genome mapping programs; rise in awareness pertaining to DNA sequencing; and increase in investment in research, development, & innovation have bolstered the market growth.

However, dearth of skilled professionals and standardization concerns in sequencing procedures impede the market growth. Conversely, the use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to offer lucrative opportunities for market players in the near future.

The Sanger’s sequencing service market is segmented based on application, end user, and region. By application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics, and other applications. Deepening on end user, it is fragmented into academic & government research institutes, pharmaceuticals companies, biotechnology companies and hospitals & clinics. Region wise, the market is classified into the following regions, namely, the United States, EU, Japan, China, India, Southeast Asia, and rest of the world (ROW).

KEY BENEFITS
•This report entails a detailed quantitative analysis of the current market trends and future estimations from 2013 to 2025 to identify the prevailing opportunities.
•Sanger’s sequencing service market size and market estimations are based on comprehensive analysis of the applications, end users, and developments in the industry.
•In-depth analysis based on region assists to understand the regional market and the strategic business planning.
•The development strategies adopted by key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Application
•Diagnostics
•Biomarkers & Cancer
•Reproductive Health
•Personalized Medicine
•Forensics
•Others

By End User
•Academic & Government Research Institutes
•Pharmaceutical Companies
•Biotechnology Companies
•Hospitals & Clinics

By Region
•United States
•EU
•Japan
•China
•India
•Southeast Asia
•Rest of the World (ROW)

The list of key players operating in this market includes:
•Source BioScience
•GenScript Biotech Corporation
•Thermo Fisher Scientific, Inc.
•LGC Science Group Limited
•Fasteris SA
•CeMIA SA
•Quintara Biosciences
•GenHunter Corporation
•Eurofins Scientific SE
•GENEWIZ
•Nucleics
•SciGenom Labs Pvt. Limited
•Microsynth AG. Inc.

The other players included in the value chain analysis (and not included in the report) include:
•Laragen, Inc.
•StarSEQ GmbH

*** レポート目次(コンテンツ)***

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market scope and definition
3.2. Competitive environment analysis

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Top player positioning, 2016
3.4. Patent analysis, 2010-2018
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Technological advancements in Sangers sequencing
3.5.1.2. Surge in applications of Sangers sequencing
3.5.1.3. Increase in genome mapping programs

3.5.2. Restraints

3.5.2.1. Lack of skilled professionals
3.5.2.2. Standardization concerns over sequencing-based diagnostics

3.5.3. Opportunities

3.5.3.1. Cloud computing serves as a potential data management service
3.5.3.2. Lucrative opportunities in the emerging markets

CHAPTER 4: GLOBAL AND REGIONAL SANGERS SEQUENCING SERVICE MARKET SHARE ANALYSIS

4.1. Global Sangers sequencing services market share analysis, 2017
4.2. U.S. Sangers sequencing services market share analysis, 2017
4.3. Europe Sangers sequencing services market share analysis, 2017
4.4. Japan Sangers sequencing services market share analysis, 2017
4.5. China Sangers sequencing services market share analysis, 2017
4.6. India Sangers sequencing services market share analysis, 2017
4.7. South-East Asia Sangers sequencing services market share analysis, 2017
4.8. Rest of the world Sangers sequencing services market share analysis, 2017

CHAPTER 5: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Diagnostics

5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region

5.3. Biomarkers & cancer

5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region

5.4. Reproductive health

5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region

5.5. Personalized medicine

5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region

5.6. Forensics

5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region

5.7. Others

5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region

CHAPTER 6: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Academic & government research institutes

6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by region

6.3. Pharmaceutical companies

6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by region

6.4. Biotechnology companies

6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by region

6.5. Hospitals & clinics

6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by region

CHAPTER 7: GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. U.S.

7.2.1. Key market trends
7.2.2. U.S. market size and forecast

7.2.2.1. U.S. Sangers sequencing service market, by application
7.2.2.2. U.S. Sangers sequencing service market, by end user

7.3. Europe

7.3.1. Key market trends
7.3.2. Europe market size and forecast

7.3.2.1. Europe Sangers sequencing service market, by application
7.3.2.2. Europe Sangers sequencing service market, by end user

7.4. Japan

7.4.1. Key market trends
7.4.2. Japan market size and forecast

7.4.2.1. Japan Sangers sequencing service market, by application
7.4.2.2. Japan Sangers sequencing service market, by end user

7.5. China

7.5.1. Key market trends
7.5.2. China market size and forecast

7.5.2.1. China Sangers sequencing service market, by application
7.5.2.2. China Sangers sequencing service market, by end user

7.6. India

7.6.1. Key market trends
7.6.2. India market size and forecast

7.6.2.1. India Sangers sequencing service market, by application
7.6.2.2. India Sangers sequencing service market, by end user

7.7. Southeast Asia

7.7.1. Key market trends
7.7.2. Southeast Asia market size and forecast

7.7.2.1. Southeast Asia Sangers sequencing service market, by application
7.7.2.2. Southeast Asia Sangers sequencing service market, by end user

7.8. Rest of the world

7.8.1. Key market trends
7.8.2. Rest of the world market size and forecast

7.8.2.1. Rest of the world Sangers sequencing service market, by application
7.8.2.2. Rest of the world Sangers sequencing service market, by end user

CHAPTER 8: COMPANY PROFILES

8.1. CeMIA SA

8.1.1. Company Profile
8.1.2. Main business/business overview
8.1.3. Products, services, and solutions
8.1.4. CeMIA Revenue (Million USD)

8.2. Fasteris SA

8.2.1. Company Profile
8.2.2. Main business/business overview
8.2.3. Products, Services, and Solutions
8.2.4. Fasteris revenue (million USD)

8.3. GENEWIZ, Inc.

8.3.1. Company Profile
8.3.2. Main business/business overview
8.3.3. Products, services, and solutions
8.3.4. GENEWIZ Revenue (Million USD)
8.3.5. Recent developments

8.4. GenHunter Corporation

8.4.1. Company Profile
8.4.2. Main business/business overview
8.4.3. Products, Services, and Solutions
8.4.4. GenHunter revenue (million USD)

8.5. Genscript Biotech Corporation

8.5.1. Company Profile
8.5.2. Main Business/Business Overview
8.5.3. Products, Services, and Solutions
8.5.4. GenScript revenue (million USD)

8.6. LGC Science Group Holdings Limited

8.6.1. Company Profile
8.6.2. Main Business/Business Overview
8.6.3. Products, Services, and Solutions
8.6.4. LGC revenue (million USD)
8.6.5. Recent developments

8.7. Microsynth AG

8.7.1. Company Profile
8.7.2. Main business/business overview
8.7.3. Products, Services, and Solutions
8.7.4. Microsynth revenue (million USD)

8.8. Nucleics Pty. Ltd.

8.8.1. Company Profile
8.8.2. Main Business/Business Overview
8.8.3. Products, Services, and Solutions
8.8.4. Nucleics revenue (million USD)

8.9. Quintara Biosciences

8.9.1. Company Profile
8.9.2. Main Business/Business Overview
8.9.3. Products, Services, and Solutions
8.9.4. Quintara revenue (million USD)
8.9.5. Recent Developments

8.10. SciGenom Labs Pvt. Ltd.

8.10.1. Company Profile
8.10.2. Main business/business overview
8.10.3. Products, Services, and Solutions
8.10.4. SciGenom Labs revenue (million USD)

8.11. Source BioScience Plc

8.11.1. Company Profile
8.11.2. Main business/business overview
8.11.3. Products, services, and solutions
8.11.4. Source BioScience revenue (million USD)

8.12. Thermo Fisher Scientific Inc.

8.12.1. Company Profile
8.12.2. Main business/business overview
8.12.3. Products, services, and solutions
8.12.4. Thermo Fisher revenue (million USD)
8.12.5. Recent developments

TABLE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 02. SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013-2025 ($MILLION)
TABLE 03. SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, BY REGION, 2013-2025 ($MILLION)
TABLE 04. SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013-2025 ($MILLION)
TABLE 05. SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013-2025 ($MILLION)
TABLE 06. SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013-2025 ($MILLION)
TABLE 07. SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, BY REGION, 2013-2025 ($MILLION)
TABLE 08. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 09. SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2025 ($MILLION)
TABLE 10. SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 11. SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2025 ($MILLION)
TABLE 12. SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013-2025 ($MILLION)
TABLE 13. SANGERS SEQUENCING SERVICE MARKET, BY REGION, 2013-2025 ($MILLION)
TABLE 14. U.S. SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 15. U.S. SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 16. Europe SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 17. Europe SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 18. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 19. JAPAN SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 20. CHINA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 21. CHINA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 22. INDIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 23. INDIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 24. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 25. SOUTHEAST ASIA SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 26. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION, 2013-2025 ($MILLION)
TABLE 27. REST OF THE WORLD SANGERS SEQUENCING SERVICE MARKET, BY END USER, 2013-2025 ($MILLION)
TABLE 28. CEMIA: COMPANY SNAPSHOT
TABLE 29. FASTERIS: COMPANY SNAPSHOT
TABLE 30. GENEWIZ: COMPANY SNAPSHOT
TABLE 31. GENHUNTER: COMPANY SNAPSHOT
TABLE 32. GENSCRIPT: COMPANY SNAPSHOT
TABLE 33. LGC: COMPANY SNAPSHOT
TABLE 34. MICROSYNTH: COMPANY SNAPSHOT
TABLE 35. NUCLEICS: COMPANY SNAPSHOT
TABLE 36. QUINTARA: COMPANY SNAPSHOT
TABLE 37. SCIGENOM LABS: COMPANY SNAPSHOT
TABLE 38. SOURCE BIOSCIENCE: COMPANY SNAPSHOT
TABLE 39. THERMO FISHER: COMPANY SNAPSHOT

FIGURE 01. GLOBAL SANGERS SEQUENCING SERVICE MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2014-2017 (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. PATENT ANALYSIS, BY YEAR
FIGURE 08. PATENT ANALYSIS, BY REGION
FIGURE 09. GLOBAL SANGERS SEQUENCING SERVICE MARKET: IMPACT ANALYSES
FIGURE 10. GLOBAL SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 11. U.S. SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 12. Europe SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 13. JAPAN SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 14. CHINA SANGERS SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2017
FIGURE 15. INDIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 16. SOUTH-EAST ASIA SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 17. REST OF THE WORLD SANGERS SEQUENCING SERVICES MARKET SHARE ANALYSIS, 2017
FIGURE 18. GLOBAL SANGERS SEQUENCING SERVICE MARKET, BY APPLICATION
FIGURE 19. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, 2013 AND 2025 ($MILLION)
FIGURE 20. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)
FIGURE 21. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)
FIGURE 22. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, 2013 AND 2025 ($MILLION)
FIGURE 23. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)
FIGURE 24. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR OTHERS, 2013 AND 2025 ($MILLION)
FIGURE 25. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)
FIGURE 26. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 27. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)
FIGURE 28. COMPARATIVE REGION ANALYSIS OF SANGERS SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)
FIGURE 29. GENSCRIPT: NET SALES, 2014-2016 ($MILLION)
FIGURE 30. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 31. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)
FIGURE 32. LGC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. SOURCE BIOSCIENCE: NET SALES, 2013-2015 ($MILLION)
FIGURE 34. SOURCE BIOSCIENCE : REVENUE SHARE BY DIVISION, 2015 ($MILLION)
FIGURE 35. THERMO FISHER: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. THERMO FISHER: REVENUE SHARE BY SEGMENT, 2017 ($MILLION)
FIGURE 37. THERMO FISHER: REVENUE SHARE BY GEOGRAPHY, 2017 ($MILLION)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • エクアドルの発電セット市場(Electric Generating Set Market in Ecuador)
    This market research report offers a perspective on the actual market situation, trends and future outlook for electric generating sets in Ecuador. The study provides essential market information for decision-makers including: - Overall market for electric generating sets in Ecuador - Market for ele …
  • (株)リハン(LEEHAN Corporation)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • ICT予算予測(中規模企業):フィンランド製造企業 – ICT予算内訳予測
    Why was the report written? This report presents the output from Kable’s ICT spend prediction statistical model, a log-linear regression model that provides ICT spending predictions based on a company’s demographic profile. The statistical model has been developed using an extensive collection of su …
  • 世界の医療向け3Dプリンティング市場2016
    2016 Global 3D Printing in Medical Applications Industry Report is a professional and in-depth research report on the world's major regional market conditions of the 3D Printing in Medical Applications industry, focusing on the main regions (North America, Europe and Asia) and the main countries (Un …
  • メンズウエア(男性服)市場:オマーン(市場規模、動向、予測)
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for menswear in Oman. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for industry executives, mar …
  • ラトビアの空気圧モーターおよびエンジン市場(~2019)
    The industry report Pneumatic Power Motor and Engine Market in Latvia to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for pneumatic power motors and engines in Latvia. The research includes historic market da …
  • 固体脂肪(Solid Fats)市場(~2017):ルーマニア
    Synopsis The report presents detailed data on consumption trends in the Solid Fats category in Romania, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers and acquisitions (of Oils and Fa …
  • 世界のインパクトプリンター市場2015
    The Global Impact printer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Impact printer industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Impact p …
  • 体外受精の北米市場
    KEY FINDINGSThe North America in-vitro fertilization market is forecasted to evolve with a CAGR of 10.11% from 2018 to 2026. Several end-user segments that deploy the IVF techniques include, cryobanks, hospitals and research laboratories, fertility and surgical centers. MARKET INSIGHTS Canada and Un …
  • 世界の歯科用タービン市場2016
    Notes:Production, means the output of Dental Turbines Revenue, means the sales value of Dental Turbines This report studies Dental Turbines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, p …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(AMR805013 )"サンガー法シーケンシングサービスの世界市場:用途別(診断、バイオマーカー・がん、リプロダクティブヘルス、オーダーメイド医療、化学捜査、その他)、エンドユーザー別(学術・政府研究機関、製薬会社、バイオテクノロジー企業、病院・診療所)" (英文:Sangers Sequencing Service Market by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics, and Others) and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics) - Global Opportunity Analysis and Industry Forecast, 2013-2025 )はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。